Nuvation Bio NUVB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$145.99M+75.9% | -$204.63M+64.0% | -$217.48M+59.1% | -$202.9M+60.3% | -$606.38M-781% | ||
| $1.97M+110% | $1.74M+155% | $1.42M+173% | $1.05M+154% | $935K+317% | ||
| $37.07M+5.7% | $35.89M+11.2% | $38.1M+47.6% | $37.55M+58.0% | $35.09M+78.0% | ||
| $631K— | $310K— | $224K— | $11K— | —— | ||
| —— | —— | —— | —— | $414K— | ||
| —— | —— | —— | $17.21M— | $2.31M— | ||
| —— | —— | —— | —— | -$3.61M— | ||
| -$2.79M-152% | $846K-86.0% | $6.84M+6,675% | $5.4M+402% | $5.4M+402% | ||
| $7.72M— | $4.42M— | —— | —— | —— | ||
| -$125.73M+20.1% | -$173.43M-33.0% | -$190M-91.6% | -$168.19M-99.7% | -$157.34M-144% | ||
| $7.98M+17,624% | $8M— | $8M+61,438% | $226K+265% | $45K-46.4% | ||
| —— | —— | —— | $189.95M+190% | $169.34M+147% | ||
| $9.94M+80.1% | $10.11M+127% | $3.24M— | $4.35M— | $5.52M— | ||
| $11.37M-35.8% | $11.9M-30.7% | $8.33M-12.6% | $11.54M+82.6% | $17.7M— | ||
| $202.03M— | $202.54M— | —— | —— | —— | ||
| -$588K-197% | -$265K-158% | $1.08M+262% | $398K+410% | $604K— | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.88M+745% | $2.25M+778% | $1.61M+845% | $976.25K+1,045% | ||
| —— | $197K-47.2% | $241K-13.9% | $285K+52.8% | $329K+253% | ||
| $631K— | $310K— | $224K— | $11K— | —— | ||
| $1.35M+646% | $1.09M— | $415K— | $205K— | -$248K— | ||
| —— | —— | $3.03M+62.1% | -$828K-160% | -$1.64M— | ||
| -$1.79M-333% | -$285K-116% | $1.39M+25.5% | $90K-91.8% | $770K-61.7% | ||
| $15.83M+112,971% | $11.41M— | $5.71M— | $552K— | $14K— | ||
| $7.72M— | $4.42M— | —— | —— | —— | ||
| -$15.22M— | -$10.14M— | -$5.12M— | -$266K— | —— | ||
| —— | —— | —— | $240K+320% | $30K+134% | ||
| $330K— | $354K— | —— | —— | —— | ||
| —— | —— | —— | -$150M— | —— | ||
| -$2.8M-1,330% | $812K-13.2% | $830K+286% | $909K+407% | $228K-79.3% | ||
| —— | —— | $4.28M— | $4.39M— | $4.31M— | ||
| —— | $3.87M+524% | $3.06M— | $2.25M— | $1.43M— | ||
| -$133.71M+15.0% | -$181.43M-39.1% | -$198M-99.7% | -$168.42M-99.9% | -$157.38M-144% | ||
| -$133.71M+15.0% | -$181.43M-39.1% | -$198M-99.7% | -$168.42M-99.9% | -$157.38M-144% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.